A phase III, multi-center, placebo-controlled, double blind, randomized, parallel group study to establish the efficacy of LLL-2011 administered as a 1% nasal spray in the preventive treatment of common migraine.
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2016
At a glance
- Drugs LLL 2011 (Primary)
- Indications Migraine without aura
- Focus Registrational; Therapeutic Use
- 07 Sep 2010 New trial record